http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201019957-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1470af2d007afa44390c8c9cfbaff5f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7e0e42cba4bee6c48312821708b5d3a |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 |
| filingDate | 2008-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0046c4dce4e01629eb9e274dfd7ea810 |
| publicationDate | 2010-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-201019957-A |
| titleOfInvention | Compositions for treating IL-20 induced kidney disease |
| abstract | The present invention is related to a composition for treating an interleukin-20 related kidney disease comprising: (I) an active component selected from the group consisting of (a) anti-interleukin-20 antibody, (b) anti-interleukin-20 receptor subunit antibody, (c) anti-interleukin-20 receptor heterodimeric polypeptide complex antibody; and (d) interleukin-20 receptor or the extracellular portion of IL-20R which is (i) a soluble or scavenger single polypeptide IL-20R receptor subunit, or (ii) a soluble or scavenger IL-20R heterodimeric polypeptide complex; and (II) a therapeutic carrier or excipient. |
| priorityDate | 2008-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 278.